SXTC
Price:
$0.573
Market Cap:
$1.99M
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and munic...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-01-04
Stock Exchange
NASDAQ
Ticker
SXTC
According to China SXT Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.16. This represents a change of 75.74% compared to the average of -0.09 of the last 4 quarters.
The mean historical PE Ratio of China SXT Pharmaceuticals, Inc. over the last ten years is 2.28K. The current -0.16 PE Ratio has changed -100.70% with respect to the historical average. Over the past ten years (40 quarters), SXTC's PE Ratio was at its highest in in the March 2018 quarter at 162.29. The PE Ratio was at its lowest in in the September 2019 quarter at -76.22.
Average
2.28K
Median
-0.46
Minimum
-9.64
Maximum
20.28K
Discovering the peaks and valleys of China SXT Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 615.71%
Maximum Annual PE Ratio = 20.28K
Minimum Annual Increase = -101.53%
Minimum Annual PE Ratio = -9.64
Year | PE Ratio | Change |
---|---|---|
2024 | -0.46 | -16.62% |
2023 | -0.56 | -45.09% |
2022 | -1.02 | -89.46% |
2021 | -9.64 | 615.71% |
2020 | -1.35 | -101.53% |
2019 | 87.79 | -11.69% |
2018 | 99.41 | -0.21% |
2017 | 99.62 | -99.51% |
The current PE Ratio of China SXT Pharmaceuticals, Inc. (SXTC) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.68
5-year avg
-2.60
10-year avg
2.28K
China SXT Pharmaceuticals, Inc.’s PE Ratio is less than Akanda Corp. (-0.11), greater than Petros Pharmaceuticals, Inc. (-0.19), greater than GelStat Corporation (-3.52), greater than Shuttle Pharmaceuticals Holdings, Inc. (-0.48), greater than Qilian International Holding Group Limited (-24.86), less than PainReform Ltd. (-0.05), greater than Regencell Bioscience Holdings Limited (-18.48), less than Procaps Group S.A. (4.69), greater than Jupiter Wellness, Inc. (-3.87), greater than Biofrontera Inc. (-0.42), greater than FSD Pharma Inc. (-0.27), less than Acorda Therapeutics, Inc. (-0.00), greater than Lucy Scientific Discovery Inc. (-0.72), less than Shionogi & Co., Ltd. (3.03), less than Sunshine Biopharma, Inc. (-0.04), greater than Alimera Sciences, Inc. (-20.57), greater than Guardion Health Sciences, Inc. (-2.89), greater than China Pharma Holdings, Inc. (-0.65), less than Halo Collective Inc. (-0.00),
Company | PE Ratio | Market cap |
---|---|---|
-0.11 | $2.11M | |
-0.19 | $3.27M | |
-3.52 | $247.19K | |
-0.48 | $3.42M | |
-24.86 | $38.68M | |
-0.05 | $1.81M | |
-18.48 | $87.06M | |
4.69 | $218.91M | |
-3.87 | $49.33M | |
-0.42 | $6.15M | |
-0.27 | $66.67K | |
-0.00 | $821.03K | |
-0.72 | $906.91K | |
3.03 | $12.78B | |
-0.04 | $3.48M | |
-20.57 | $302.38M | |
-2.89 | $17.02M | |
-0.65 | $3.04M | |
-0.00 | $895.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China SXT Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like China SXT Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is China SXT Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for China SXT Pharmaceuticals, Inc. (SXTC)?
What is the highest PE Ratio for China SXT Pharmaceuticals, Inc. (SXTC)?
What is the 3-year average PE Ratio for China SXT Pharmaceuticals, Inc. (SXTC)?
What is the 5-year average PE Ratio for China SXT Pharmaceuticals, Inc. (SXTC)?
How does the current PE Ratio for China SXT Pharmaceuticals, Inc. (SXTC) compare to its historical average?